Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Calidi Biotherapeutics, Inc. (CLDI) had Operating Cash Flow per Share of $-4.95 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-25.58M |
|
-- |
|
-- |
|
$20.24M |
|
$-20.24M |
|
$0.19M |
|
$-20.05M |
|
$-20.29M |
|
$-20.06M |
|
$-20.06M |
|
$-20.06M |
|
$-20.31M |
|
$-20.24M |
|
$-18.59M |
|
4.30M |
|
4.30M |
|
$-5.95 |
|
$-5.95 |
|
| Balance Sheet Financials | |
$6.26M |
|
$0.78M |
|
$2.60M |
|
$8.86M |
|
$3.94M |
|
$0.77M |
|
$1.16M |
|
$5.10M |
|
$3.76M |
|
$3.76M |
|
$3.76M |
|
7.22M |
|
| Cash Flow Statement Financials | |
$-21.29M |
|
$-0.17M |
|
$17.46M |
|
$9.81M |
|
$5.82M |
|
$-3.99M |
|
$2.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.59 |
|
-- |
|
-- |
|
0.17 |
|
0.23 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-21.41M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-533.73% |
|
-533.73% |
|
-226.52% |
|
-442.89% |
|
$0.52 |
|
$-4.98 |
|
|
Operating Cash Flow per Share |
$-4.95 |